Clinical effects on the chemotherapy of neoadjuvent chomotherapy for surgical resection in patients with stage ⅢA non-small cell lung cancer
- VernacularTitle:新辅助化疗对ⅢA期非小细胞肺癌手术疗效的影响
- Author:
Yongsheng LI
;
Wendong YANG
;
Yukong HUANG
;
Wei WEI
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small cell lung;
Drug therapy;
Surgical procedures,operative
- From:
Chinese Journal of Primary Medicine and Pharmacy
2005;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of neoadjuvent chomotherapy of paclitexel plus eisplatin for improving the surgical resection rate of stage ⅢA non-small cell lung cancer(NSCLC).Methods 46 patients with stage ⅢA NSCLC were randomly divided into neoadjuvant chemotherapy group(25 caeses) and simple operative group(25 cases).Neoedjuvant chemotherapy group(NCG) received two-cycle chemotherapy and then underwent operation.Simple operative group(SOG) was only treated by operation.Results The operative resection rate of NCG was 99.0%,radical resection rate was 64.0%.It was higher obviously than that simple operative group(SOG)(P
